Prenetics Sells ACT Genomics Stake for $71.78 Million to Strengthen Bitcoin Financial Strategy

Nasdaq-listed company Prenetics has announced that it has reached a definitive agreement to transfer its ownership in ACT Genomics Holdings Company Limited to Delta Electronics, Inc. for approximately $71.78 million. The divestment of ACT Genomics has significantly strengthened Prenetics’ financial position, with cash reserves expected to reach around $86 million and total cash and short-term assets projected at $117 million. The company maintains a debt-free balance sheet, enabling it to explore other financial management options, including the adoption of digital assets and Bitcoin treasury strategies. (Globenewswire)